InsiderTrades

Form 4 for TECH Bio-Techne

Accepted 2022-08-09 00:00:00 ET · period of report 2022-08-07 · accession 0001437749-22-019663 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-08-09 2022-08-07 TECH Kummeth Charles R. CEO, Dir M - OptEx $0.00 +16.9K 252.0K +7% $0
D 2022-08-09 2022-08-07 TECH Kummeth Charles R. CEO, Dir F - Tax $382.97 -11.6K 240.4K -5% -$4.43M
D 2022-08-09 2022-08-07 TECH Kummeth Charles R. CEO, Dir M - OptEx $0.00 -16.9K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-08-07 M A 16,918 $0.00 251,960 D — — (F1) Includes (i) 2,862 shares of restricted stock for which the risk of forfeiture will lapse on August 5, 2023; and (ii) 3,562 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on each of August 6, 2023 and August 6, 2024.
2 Common Common Stock 2022-08-07 F D 11,557 $382.97 240,403 D — — (F1) Includes (i) 2,862 shares of restricted stock for which the risk of forfeiture will lapse on August 5, 2023; and (ii) 3,562 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on each of August 6, 2023 and August 6, 2024.
3 Derivative Restricted Stock Units 2022-08-07 M D 16,937 $0.00 0 D — · — to — 16,937 Common Stock (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F4) On 8/7/2022, the Board of Directors certified vesting of 16,937 performance RSUs.